Global Pelvic Floor Repair Mesh Market

Overview

This report from Life Science Intelligence provides the latest market data for the Global Pelvic Floor Repair Mesh Market. Information covered by this report includes:

·        unit volumes & pricing forecast from 2019-2024

·        analyses of the leading companies, and

·        global market share analysis.

The global market for pelvic floor repair mesh was valued at an estimated $106.5 million in 2020 and is expected to grow at a CAGR (2020-2024) of 4.9%. Products covered by this report include implantable pelvic floor meshes for pelvic floor repair and reconstruction procedures.

This report covers the impact of COVID-19 on the pelvic floor repair mesh market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as BD, Boston Scientific, Cook Medical, Johnson & Johnson subsidiary Ethicon, and others. The report provides insights into trends, drivers, and limiters of the pelvic floor repair mesh market, as well as highlights potential opportunities.

The hernia repair mesh market was negatively impacted by the COVID-19 pandemic. The pandemic has affected elective surgical procedures markedly, as many non-critical procedures have been cancelled or postponed so that healthcare resources have been conserved for the treatment of COVID-19 and other critically ill patients. The market and procedures utilizing these products are projected to slowly recover in 2021.

The leading players in the pelvic floor repair mesh market are Ethicon (J&J), BD, Cook Medical, and Boston Scientific. The surgical mesh market has seen extensive product recalls and personal injury litigation from patients in the last decade. As part of the FDA’s rigorous monitoring of the safety and efficacy of surgical meshes the leading marketed surgical meshes from Boston Scientific (Uphold LITE and Xenform) and Coloplast (Restorelle DirectFix Anterior) are undergoing post-market surveillance studies. The outcomes of the study and alternative biomaterials will potentially allay the patient concerns and lead to stronger market growth in the future.